PAVmed Net Income Over Time

PAVM Stock  USD 10.96  0.01  0.09%   
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out PAVmed Performance and PAVmed Correlation.
At this time, PAVmed's Net Income From Continuing Ops is very stable compared to the past year. As of the 11th of February 2026, Net Income is likely to grow to about 26.9 M, though Net Loss is likely to grow to (76.3 M).
Will Health Care Equipment & Supplies sector continue expanding? Could PAVmed diversify its offerings? Factors like these will boost the valuation of PAVmed. Anticipated expansion of PAVmed directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every PAVmed data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share
(12.00)
Revenue Per Share
0.054
Quarterly Revenue Growth
(0.99)
Return On Assets
(0.37)
Return On Equity
0.1744
Understanding PAVmed Inc requires distinguishing between market price and book value, where the latter reflects PAVmed's accounting equity. The concept of intrinsic value - what PAVmed's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push PAVmed's price substantially above or below its fundamental value.
It's important to distinguish between PAVmed's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding PAVmed should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, PAVmed's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
Specify up to 10 symbols:

Cross Equities Net Income Analysis

Compare PAVmed Inc and related stocks such as DIH Holdings US, Inspira Technologies Oxy, and Pheton Holdings Net Income Over Time
Select Fundamental
Price To Sales RatioDividend Yield
Ptb RatioDays Sales Outstanding
Book Value Per ShareFree Cash Flow Yield
Invested CapitalOperating Cash Flow Per Share
Average PayablesStock Based Compensation To Revenue
Capex To DepreciationPb Ratio
Ev To SalesFree Cash Flow Per Share
RoicInventory Turnover
Net Income Per ShareDays Of Inventory On Hand
Payables TurnoverSales General And Administrative To Revenue
Average InventoryResearch And Ddevelopement To Revenue
Capex To RevenueCash Per Share
PocfratioInterest Coverage
Payout RatioCapex To Operating Cash Flow
Pfcf RatioDays Payables Outstanding
Net Current Asset ValueIncome Quality
RoeTangible Asset Value
Ev To Operating Cash FlowPe Ratio
Return On Tangible AssetsEv To Free Cash Flow
Earnings YieldIntangibles To Total Assets
Net Debt To E B I T D ACurrent Ratio
Tangible Book Value Per ShareReceivables Turnover
Shareholders Equity Per ShareDebt To Equity
Capex Per ShareGraham Net Net
Average ReceivablesRevenue Per Share
Interest Debt Per ShareDebt To Assets
Enterprise Value Over E B I T D AShort Term Coverage Ratios
Price Earnings RatioOperating Cycle
Price Book Value RatioPrice Earnings To Growth Ratio
Days Of Payables OutstandingDividend Payout Ratio
Price To Operating Cash Flows RatioPrice To Free Cash Flows Ratio
Pretax Profit MarginEbt Per Ebit
Operating Profit MarginEffective Tax Rate
Company Equity MultiplierLong Term Debt To Capitalization
Total Debt To CapitalizationReturn On Capital Employed
Debt Equity RatioEbit Per Revenue
Quick RatioDividend Paid And Capex Coverage Ratio
Net Income Per E B TCash Ratio
Cash Conversion CycleOperating Cash Flow Sales Ratio
Days Of Inventory OutstandingDays Of Sales Outstanding
Free Cash Flow Operating Cash Flow RatioCash Flow Coverage Ratios
Price To Book RatioFixed Asset Turnover
Capital Expenditure Coverage RatioPrice Cash Flow Ratio
Enterprise Value MultipleDebt Ratio
Cash Flow To Debt RatioPrice Sales Ratio
Return On AssetsAsset Turnover
Net Profit MarginGross Profit Margin
Price Fair ValueReturn On Equity
20102011201220132014201520162017201820192020202120222023202420252026
DHAI(10.9 M)(10.9 M)(10.9 M)(10.9 M)(10.9 M)(10.9 M)(10.9 M)(10.9 M)(10.9 M)(10.9 M)(10.9 M)(12.1 M)(2.4 M)(8.4 M)(8.4 M)(8.7 M)(9.1 M)
IINN(39.6 K)(39.6 K)(39.6 K)(39.6 K)(39.6 K)(39.6 K)(39.6 K)(39.6 K)(39.6 K)(4.6 M)(7.2 M)(17 M)(4 M)(11.3 M)(11.1 K)(9.9 K)(10.4 K)
TNON(509.6 K)(509.6 K)(509.6 K)(509.6 K)(509.6 K)(509.6 K)(509.6 K)(509.6 K)(509.6 K)(509.6 K)(585.2 K)(7 M)(18.9 M)(15.6 M)(13.7 M)(12.3 M)(12.9 M)
BMRA(1.9 M)548.4 K537 K(215.7 K)(331.4 K)(1.5 M)(908.6 K)(1.5 M)(2.4 M)(2.3 M)(7.4 M)(4.5 M)(7.1 M)(6 M)(5 M)(4.5 M)(4.3 M)
HSCS(3.8 M)(3.8 M)(3.8 M)(3.8 M)(3.8 M)(3.8 M)(3.8 M)(3.8 M)(3.8 M)(3.8 M)(2.5 M)(4.8 M)(6.4 M)(6.6 M)(8.8 M)(7.9 M)(8.3 M)
SSKN(2.3 M)(20.4 M)(22.7 M)(25.9 M)(16 M)(27.9 M)(3.3 M)(21.5 M)(4 M)(3.8 M)(4.4 M)(2.7 M)(5.5 M)(10.8 M)(10.1 M)(9.1 M)(9.5 M)
APVO(53.3 M)(53.3 M)(53.3 M)(53.3 M)(51.1 M)(59.3 M)(112.4 M)M(53.7 M)(44.7 M)(17.8 M)(27.3 M)M(17.4 M)(24.1 M)(27.7 M)(29.1 M)
ADVB(1.8 M)(1.8 M)(1.8 M)(1.8 M)(1.8 M)(1.8 M)(1.8 M)(1.8 M)(1.8 M)(1.8 M)(1.8 M)(142.4 K)(121.5 K)(87.4 K)(101.5 K)(116.8 K)(122.6 K)
BNR(131.3 M)(131.3 M)(131.3 M)(131.3 M)(131.3 M)(131.3 M)(131.3 M)(131.3 M)(177.5 M)(168.3 M)(407.2 M)(796.7 M)(971.2 M)(653.7 M)(346.6 M)(312 M)(327.6 M)

PAVmed Inc and related stocks such as DIH Holdings US, Inspira Technologies Oxy, and Pheton Holdings Net Income description

Net income is one of the most important fundamental items in finance. It plays a large role in PAVmed Inc financial statement analysis. It represents the amount of money remaining after all of PAVmed Inc operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.

My Equities

My Current Equities and Potential Positions

PAVmed Inc
PAVM
Specialization
Health Care, Health Care Equipment & Services
Business Address360 Madison Avenue,
ExchangeNASDAQ Exchange
USD 10.96
When determining whether PAVmed Inc is a strong investment it is important to analyze PAVmed's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact PAVmed's future performance. For an informed investment choice regarding PAVmed Stock, refer to the following important reports:
Check out PAVmed Performance and PAVmed Correlation.
You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
PAVmed technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of PAVmed technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of PAVmed trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...